c ebpβ-lip drug A review of C/EBP α: a potential novel target for solid tumor intervention | Journal of Translational Medicine The C/EBPβ LIP isoform rescues
The C EBP LIP isoform rescues loss of C EBP function in the mouse Scientific Reports C EBP: The structure, regulation, and its roles in inflammation related diseases ScienceDirect C EBP beta (LAP) Antibody Cell Signaling Technology C EBP LIP induces a tumor menagerie making it an oncogene Journal of Molecular Medicine Springer Nature Link Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research Springer Nature Link C EBP sustains the oncogenic program of AML cells by cooperating with MYB and co activator p300 in a transcriptional module Experimental Hematology
Pay in 4 interest-free payments of $5.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




